Table 5. Choice of influenza vaccine for selected age and risk groups (for persons without a contraindication to the vaccine).

Recipient by age group	Vaccine types available for use	Preferred vaccine for healthy persons	Preferred vaccine for persons with chronic health conditions	Comments
Children 6–23 months of age	TIV	-	-	Only TIV is available for this age group
Children 2–17 years of age	TIV LAIV	LAIV	No preference	Children with immune compromising conditions: • LAIV not recommended
Adults 18–59 years of age	TIV TIV-ID (9 µg) LAIV	No preference	TIV TIV-ID (9 µg)	Adults with immune compromising conditions: • LAIV not recommended • TIV-ID 15 µg formulation can be considered
Adults 60–64 years of age	TIV TIV-ID (15 µg)	No preference	No preference
Adults 65+ years of age	TIV TIV-ID (15 µg) MF59-adjuvanted TIV	No preference	No preference
Pregnant women	TIV TIV-ID (9 µg)	No preference	No preference	LAIV not recommended

TIV = trivalent inactivated influenza vaccine (for IM administration); TIV-ID = trivalent inactivated influenza vaccine for intradermal injection; LAIV = live attenuated influenza vaccine